Sherwin-Williams (SHW)

The real story isn't the 8% price hike, it's the 57 store closures that management buried in the prepared remarks, the most aggressive pruning in decades while still claiming growth. The market sees steady execution but I see a company quietly restructuring its footprint while using Souvenir and non-operating items to mask consumer brands weakness. The binding constraint isn't demand or inflation, it's their inability to pass through costs without hemorrhaging volume, hence the surgical store cuts. Heidi's tell: 'We know growth will need to come from what we do, not from what the market gives us.' My view changes if Q3 shows volume growth without store closures or if they detail those CBG non-operating items.